Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 May;63(5):1906–1913. doi: 10.1128/iai.63.5.1906-1913.1995

Human immunoglobulin M paraproteins cross-reactive with Neisseria meningitidis group B polysaccharide and fetal brain.

F H Azmi 1, A H Lucas 1, H L Spiegelberg 1, D M Granoff 1
PMCID: PMC173242  PMID: 7729901

Abstract

Three hundred fifty-nine serum samples from patients with immunoglobulin M (IgM) or IgG monoclonal gammopathies were tested for binding to the capsular polysaccharide (PS) of Neisseria meningitidis group B (MenB PS, poly-alpha[2-->8]-N-acetylneuraminic acid). Of 159 IgM paraproteins, 7 (4.4%) were positive, compared with 0 of 200 IgG paraproteins (P < 0.05). Since MenB PS reactivity was limited to the IgM paraproteins, the 159 IgM paraproteins were tested by enzyme-linked immunosorbent assay (ELISA) for reactivity with seven other bacterial PSs. None reacted with meningococcal A or C, Haemophilus influenzae type b, or Streptococcus pneumoniae type 3, 6, 14, or 23 PS. The specificity of the MenB PS-reactive antibodies was confirmed by demonstration of binding to N. meningitidis group B cells but not to a capsular PS-deficient mutant and by specific inhibition of binding to solid-phase MenB PS by soluble MenB PS in an ELISA. Five of five antibodies tested protected infant rats from bacteremia caused by Escherichia coli K1, an organism with a PS capsule that also is composed of poly-alpha[2-->8]-N-acetylneuraminic acid. Each of the seven MenB PS-reactive paraproteins had autoantibody activity as defined by binding to homogenates of calf brain in a radioimmunoassay. For six of the seven antibodies, binding to calf brain was inhibited by the addition of soluble MenB PS. Thus, approximately 4% of human IgM paraproteins have autoantibody activity to poly-alpha[2-->8]-N-acetylneuraminic acid, an antigen expressed in fetal brain and cross-reactive with the MenB capsular PS. The reason for this skewing of the IgM paraprotein repertoire toward reactivity with poly-alpha[2-->8]-N-acetylneuraminic acid antigenic determinants is unknown.

Full Text

The Full Text of this article is available as a PDF (352.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adderson E. E., Azmi F. H., Wilson P. M., Shackelford P. G., Carroll W. L. The human VH3b gene subfamily is highly polymorphic. J Immunol. 1993 Jul 15;151(2):800–809. [PubMed] [Google Scholar]
  2. Azmi F. H., Lucas A. H., Raff H. V., Granoff D. M. Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1. Infect Immun. 1994 May;62(5):1776–1786. doi: 10.1128/iai.62.5.1776-1786.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bosch E. P., Smith B. E. Peripheral neuropathies associated with monoclonal proteins. Med Clin North Am. 1993 Jan;77(1):125–139. doi: 10.1016/s0025-7125(16)30276-0. [DOI] [PubMed] [Google Scholar]
  4. Burger D., Perruisseau G., Steck A. J. Anti-myelin-associated glycoprotein antibodies in patients with a monoclonal IgM gammopathy and polyneuropathy, and a simplified method for the preparation of glycolipid antigens. J Immunol Methods. 1991 Jun 24;140(1):31–36. doi: 10.1016/0022-1759(91)90123-w. [DOI] [PubMed] [Google Scholar]
  5. CHRISTENSON W. N., DACIE J. V. Serum proteins in acquired haemolytic anaemia (auto-antibody type). Br J Haematol. 1957 Apr;3(2):153–164. doi: 10.1111/j.1365-2141.1957.tb05782.x. [DOI] [PubMed] [Google Scholar]
  6. Carlone G. M., Frasch C. E., Siber G. R., Quataert S., Gheesling L. L., Turner S. H., Plikaytis B. D., Helsel L. O., DeWitt W. E., Bibb W. F. Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. J Clin Microbiol. 1992 Jan;30(1):154–159. doi: 10.1128/jcm.30.1.154-159.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chacko A., Granoff D. M. In vitro induction of IgG1 and IgG2 secretion by B cells of children who developed invasive haemophilus disease despite vaccination. Pediatr Res. 1991 Jul;30(1):124–129. doi: 10.1203/00006450-199107000-00024. [DOI] [PubMed] [Google Scholar]
  8. Crisp D., Pruzanski W. B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins). Am J Med. 1982 Jun;72(6):915–922. doi: 10.1016/0002-9343(82)90852-x. [DOI] [PubMed] [Google Scholar]
  9. Devi S. J., Robbins J. B., Schneerson R. Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7175–7179. doi: 10.1073/pnas.88.16.7175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Devi S. J., Schneerson R., Egan W., Vann W. F., Robbins J. B., Shiloach J. Identity between polysaccharide antigens of Moraxella nonliquefaciens, group B Neisseria meningitidis, and Escherichia coli K1 (non-O acetylated). Infect Immun. 1991 Feb;59(2):732–736. doi: 10.1128/iai.59.2.732-736.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Emmrich F., Bundle D., van der Zee J., Out T., Zenke G., Eichmann K. Two human IgM myeloma proteins with unusual specificities for streptococcal carbohydrate-associated epitopes. Scand J Immunol. 1985 Feb;21(2):119–126. doi: 10.1111/j.1365-3083.1985.tb01410.x. [DOI] [PubMed] [Google Scholar]
  12. Finne J., Leinonen M., Mäkelä P. H. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet. 1983 Aug 13;2(8346):355–357. doi: 10.1016/s0140-6736(83)90340-9. [DOI] [PubMed] [Google Scholar]
  13. Glode M. P., Robbins J. B., Liu T. Y., Gotschlich E. C., Orskov I., Orskov F. Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92. J Infect Dis. 1977 Jan;135(1):94–104. doi: 10.1093/infdis/135.1.94. [DOI] [PubMed] [Google Scholar]
  14. Goldschneider I., Gotschlich E. C., Artenstein M. S. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med. 1969 Jun 1;129(6):1307–1326. doi: 10.1084/jem.129.6.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Griffiss J. M. Bactericidal activity of meningococcal antisera. Blocking by IgA of lytic antibody in human convalescent sera. J Immunol. 1975 Jun;114(6):1779–1784. [PubMed] [Google Scholar]
  16. Hannestad K., Sletten K. Multiple M-components in a single individual. 3. Heterogeneity of M-components in two macroglobulinemia sera with anti-polysaccharide activity. J Biol Chem. 1971 Nov 25;246(22):6982–6990. [PubMed] [Google Scholar]
  17. Ilyas A. A., Quarles R. H., MacIntosh T. D., Dobersen M. J., Trapp B. D., Dalakas M. C., Brady R. O. IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside. Proc Natl Acad Sci U S A. 1984 Feb;81(4):1225–1229. doi: 10.1073/pnas.81.4.1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jain R., Roncella S., Hashimoto S., Carbone A., Francia di Celle P., Foa R., Ferrarini M., Chiorazzi N. A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma. J Immunol. 1994 Jul 1;153(1):45–52. [PubMed] [Google Scholar]
  19. Kabat E. A., Liao J., Bretting H., Franklin E. C., Geltner D., Frangione B., Koshland M. E., Shyong J., Osserman E. F. Human monoclonal macroglobulins with specificity for Klebsiella K polysaccharides that contain 3,4-pyruvylated-D-galactose and 4,6-pyruvylated-D-galactose. J Exp Med. 1980 Oct 1;152(4):979–995. doi: 10.1084/jem.152.4.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kabat E. A., Nickerson K. G., Liao J., Grossbard L., Osserman E. F., Glickman E., Chess L., Robbins J. B., Schneerson R., Yang Y. H. A human monoclonal macroglobulin with specificity for alpha(2----8)-linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which crossreacts with polynucleotides and with denatured DNA. J Exp Med. 1986 Aug 1;164(2):642–654. doi: 10.1084/jem.164.2.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kasper D. L., Winkelhake J. L., Zollinger W. D., Brandt B. L., Artenstein M. S. Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis. J Immunol. 1973 Jan;110(1):262–268. [PubMed] [Google Scholar]
  22. Kim K. S., Cross A. S., Zollinger W., Sadoff J. Prevention and therapy of experimental Escherichia coli infection with monoclonal antibody. Infect Immun. 1985 Dec;50(3):734–737. doi: 10.1128/iai.50.3.734-737.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Konrad R. J., Kricka L. J., Goodman D. B., Goldman J., Silberstein L. E. Brief report: myeloma-associated paraprotein directed against the HIV-1 p24 antigen in an HIV-1-seropositive patient. N Engl J Med. 1993 Jun 24;328(25):1817–1819. doi: 10.1056/NEJM199306243282505. [DOI] [PubMed] [Google Scholar]
  24. Kyle R. A., Garton J. P. The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc. 1987 Aug;62(8):719–731. doi: 10.1016/s0025-6196(12)65225-2. [DOI] [PubMed] [Google Scholar]
  25. Mandrell R. E., Zollinger W. D. Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants. J Immunol. 1982 Nov;129(5):2172–2178. [PubMed] [Google Scholar]
  26. Merlini G., Farhangi M., Osserman E. F. Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias. Semin Oncol. 1986 Sep;13(3):350–365. [PubMed] [Google Scholar]
  27. Musher D. M., Groover J. E., Rowland J. M., Watson D. A., Struewing J. B., Baughn R. E., Mufson M. A. Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clin Infect Dis. 1993 Jul;17(1):66–73. doi: 10.1093/clinids/17.1.66. [DOI] [PubMed] [Google Scholar]
  28. Nicoletti C., Borghesi-Nicoletti C., Yang X. H., Schulze D. H., Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice. II. Phosphorylcholine-antibody in young and aged mice differ in both VH/VL gene repertoire and in specificity. J Immunol. 1991 Oct 15;147(8):2750–2755. [PubMed] [Google Scholar]
  29. Nicoletti C., Cerny J. The repertoire diversity and magnitude of antibody responses to bacterial antigens in aged mice: I. Age-associated changes in antibody responses differ according to the mouse strain. Cell Immunol. 1991 Mar;133(1):72–83. doi: 10.1016/0008-8749(91)90180-j. [DOI] [PubMed] [Google Scholar]
  30. Nobile-Orazio E., Marmiroli P., Baldini L., Spagnol G., Barbieri S., Moggio M., Polli N., Polli E., Scarlato G. Peripheral neuropathy in macroglobulinemia: incidence and antigen-specificity of M proteins. Neurology. 1987 Sep;37(9):1506–1514. doi: 10.1212/wnl.37.9.1506. [DOI] [PubMed] [Google Scholar]
  31. Peeters C. C., Tenbergen-Meekes A. M., Haagmans B., Evenberg D., Poolman J. T., Zegers B. J., Rijkers G. T. Pneumococcal conjugate vaccines. Immunol Lett. 1991 Oct;30(2):267–274. doi: 10.1016/0165-2478(91)90036-a. [DOI] [PubMed] [Google Scholar]
  32. Peltola H. Meningococcal disease: still with us. Rev Infect Dis. 1983 Jan-Feb;5(1):71–91. doi: 10.1093/clinids/5.1.71. [DOI] [PubMed] [Google Scholar]
  33. Phipps D. C., West J., Eby R., Koster M., Madore D. V., Quataert S. A. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J Immunol Methods. 1990 Dec 31;135(1-2):121–128. doi: 10.1016/0022-1759(90)90264-v. [DOI] [PubMed] [Google Scholar]
  34. Pinner R. W., Gellin B. G., Bibb W. F., Baker C. N., Weaver R., Hunter S. B., Waterman S. H., Mocca L. F., Frasch C. E., Broome C. V. Meningococcal disease in the United States--1986. Meningococcal Disease Study Group. J Infect Dis. 1991 Aug;164(2):368–374. doi: 10.1093/infdis/164.2.368. [DOI] [PubMed] [Google Scholar]
  35. Pruzanski W., Jacobs H., Saito S., Donnelly E. M., Lui L. C. Cryptic cold agglutinin activity of monoclonal macroglobulins. Am J Hematol. 1987 Oct;26(2):167–174. doi: 10.1002/ajh.2830260207. [DOI] [PubMed] [Google Scholar]
  36. Quagliarello V., Scheld W. M. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med. 1992 Sep 17;327(12):864–872. doi: 10.1056/NEJM199209173271208. [DOI] [PubMed] [Google Scholar]
  37. Raff H. V., Bradley C., Brady W., Donaldson K., Lipsich L., Maloney G., Shuford W., Walls M., Ward P., Wolff E. Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1. J Infect Dis. 1991 Feb;163(2):346–354. doi: 10.1093/infdis/163.2.346. [DOI] [PubMed] [Google Scholar]
  38. Raff H. V., Devereux D., Shuford W., Abbott-Brown D., Maloney G. Human monoclonal antibody with protective activity for Escherichia coli K1 and Neisseria meningitidis group B infections. J Infect Dis. 1988 Jan;157(1):118–126. doi: 10.1093/infdis/157.1.118. [DOI] [PubMed] [Google Scholar]
  39. Riesen W., Rudikoff S., Oriol R., Potter M. An IgM Waldenström with specificity against phosphorylcholine. Biochemistry. 1975 Mar 11;14(5):1052–1057. doi: 10.1021/bi00676a026. [DOI] [PubMed] [Google Scholar]
  40. Robbins J. B., Parke J. C., Jr, Schneerson R., Whisnant J. K. Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res. 1973 Mar;7(3):103–110. doi: 10.1203/00006450-197303000-00001. [DOI] [PubMed] [Google Scholar]
  41. Rougon G., Dubois C., Buckley N., Magnani J. L., Zollinger W. A monoclonal antibody against meningococcus group B polysaccharides distinguishes embryonic from adult N-CAM. J Cell Biol. 1986 Dec;103(6 Pt 1):2429–2437. doi: 10.1083/jcb.103.6.2429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sarff L. D., McCracken G. H., Schiffer M. S., Glode M. P., Robbins J. B., Orskov I., Orskov F. Epidemiology of Escherichia coli K1 in healthy and diseased newborns. Lancet. 1975 May 17;1(7916):1099–1104. doi: 10.1016/s0140-6736(75)92496-4. [DOI] [PubMed] [Google Scholar]
  43. Schneerson R., Bradshaw M., Whisnant J. K., Myerowitz R. L., Parke J. C., Jr, Robbins J. B. An Escherichia coli antigen cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b: occurrence among known serotypes, and immunochemical and biologic properties of E. coli antisera toward H. influenzae type b. J Immunol. 1972 Jun;108(6):1551–1562. [PubMed] [Google Scholar]
  44. Skevakis L., Frasch C. E., Zahradnik J. M., Dolin R. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis. J Infect Dis. 1984 Mar;149(3):387–396. doi: 10.1093/infdis/149.3.387. [DOI] [PubMed] [Google Scholar]
  45. Stevenson F. K., Smith G. J., North J., Hamblin T. J., Glennie M. J. Identification of normal B-cell counterparts of neoplastic cells which secrete cold agglutinins of anti-I and anti-i specificity. Br J Haematol. 1989 May;72(1):9–15. doi: 10.1111/j.1365-2141.1989.tb07643.x. [DOI] [PubMed] [Google Scholar]
  46. Swartley J. S., Stephens D. S. Identification of a genetic locus involved in the biosynthesis of N-acetyl-D-mannosamine, a precursor of the (alpha 2-->8)-linked polysialic acid capsule of serogroup B Neisseria meningitidis. J Bacteriol. 1994 Mar;176(5):1530–1534. doi: 10.1128/jb.176.5.1530-1534.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Tomer Y., Shoenfeld Y. Ageing and autoantibodies. Autoimmunity. 1988;1(2):141–149. doi: 10.3109/08916938809001927. [DOI] [PubMed] [Google Scholar]
  48. Wotherspoon A. C., Ortiz-Hidalgo C., Falzon M. R., Isaacson P. G. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991 Nov 9;338(8776):1175–1176. doi: 10.1016/0140-6736(91)92035-z. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES